---
title: "China's DNA sequencing market set to reach $3.1 billion by 2030 with a 21.5% CAGR growth; driven by government support and innovation."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263799377.md"
description: "China's DNA sequencing market is projected to grow from $1.2 billion in 2025 to $3.1 billion by 2030, with a CAGR of 21.5%, according to BCC Research. This growth is fueled by government support, the Precision Medicine Plan, and rising demand for precision medicine and oncology genomics. Key players like BGI Genomics and Novogene are thriving, while AI advancements are transforming the industry. The report offers insights for stakeholders aiming to leverage opportunities in this expanding sector."
datetime: "2025-10-31T18:56:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263799377.md)
  - [en](https://longbridge.com/en/news/263799377.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263799377.md)
---

# China's DNA sequencing market set to reach $3.1 billion by 2030 with a 21.5% CAGR growth; driven by government support and innovation.

A recent study by BCC Research predicts that the Chinese Market for DNA Sequencing will increase from $1.2 billion in 2025 to $3.1 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 21.5%. The report analyzes various aspects of the market in China, including products, technologies, applications, end-users, and key provinces. Factors driving this growth include government investments and strategic initiatives like the Precision Medicine Plan, making DNA sequencing more affordable and accessible. The demand for precision medicine and oncology genomics is also on the rise, leading to increased adoption of sequencing technologies. Domestic firms like BGI Genomics and Novogene are experiencing rapid growth, and advancements in AI-powered sequencing are reshaping the competitive landscape. This report provides valuable insights for stakeholders looking to capitalize on China's expanding DNA sequencing sector, driven by national healthcare ambitions and technological advancements.

### Related Stocks

- [300676.CN](https://longbridge.com/en/quote/300676.CN.md)

## Related News & Research

- [Pure Tungsten Completes Merger with GB Innovation Co., Ltd., Advancing Toward Near-Term Production and Planned Public Listing](https://longbridge.com/en/news/286944364.md)
- [UK government bolsters antiviral supply for hantavirus](https://longbridge.com/en/news/286942211.md)
- [PRECIOUS-Treasury yields, dollar weigh on gold amid inflation concerns](https://longbridge.com/en/news/286929968.md)
- [Tim Lamb Group Completes Sale of Seven Firelands Automotive Group Dealerships in Northern Ohio](https://longbridge.com/en/news/286806685.md)
- [JR West Real Estate unit hosts cultural exchange event tied to Osaka Art & Design 2026](https://longbridge.com/en/news/287009307.md)